Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • There are more 471 FDCs relating to Vitamins, Minerals and Micronutrients, etc., which have been declared as rational by Prof. Kokate Committee and a report of the committee has been accepted by the Ministry. And CDSCO asks manufacturers to get licenses from State Licensing Authorities.

  • AbbVie announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant, an orally administered calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) met its primary endpoint of statistically significantly greater reduction in mean monthly migraine days, compared to placebo, for all doses across the 12-week treatment period.

Subscribe to Pharma News